# Azitra, Inc. (AZTR) · Edgar & Edgarette company card

> Azitra (AZTR) saw revenue fall 100% in FY2025 to $0 million, operating margin null against a -3.8% median for pharmaceutical preparations, equity 75.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1701478 · fiscal year ended 2025-12-31 · 4 audited years read · [page](https://www.pops4.com/boards/company/AZTR) · [JSON](https://www.pops4.com/boards/company/AZTR.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $0 |
| Revenue growth, 1 year | -100.0% |
| Revenue growth per year | — |
| Operating margin | -Infinity% (prior year -146468.5%) |
| Net margin | -Infinity% |
| Operating cash flow | −$11M |
| Capital spending | $24,213 |
| Free cash flow | −$11M |
| Cash | $2M |
| Long-term debt | — |
| Total assets | $5M |
| Total equity | $4M |
| Equity ÷ assets | 75.6% |
| Return on equity | -288.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -53.31 (distress zone)
- Piotroski F: 1 of 9 (weak)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative (-$11.2M in FY2025); operating loss: a margin of -Infinity% in FY2025

## Edgarette's reading

Exposure: revenue $0K (FY2025). Experience: revenue down 100.0% on the year; operating margin null, down from -146468.5%. Soundness: equity 75.6% of assets, return on equity -288.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $0K and $0K next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin null against a -3.8% median; growth -100.0% against 13.7%.

Range logged 2026-09-20, receipt 29e5ffd878c8da13, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 2, latest 2026-03-13 ([filing](https://www.sec.gov/Archives/edgar/data/1701478/000149315226010108/0001493152-26-010108-index.htm))

## Recent filings

- 8-K · filed 2026-10-29 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701478/000149315226049191/0001493152-26-049191-index.htm)
- 8-K · filed 2026-10-26 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701478/000149315226048431/0001493152-26-048431-index.htm)
- 8-K · filed 2026-10-22 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701478/000149315226048103/0001493152-26-048103-index.htm)
- 8-K · filed 2026-10-01 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701478/000149315226045260/0001493152-26-045260-index.htm)
- 8-K · filed 2026-09-28 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701478/000149315226044605/0001493152-26-044605-index.htm)
- 8-K · filed 2026-09-08 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1701478/000149315226041706/0001493152-26-041706-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001701478.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1701478

## Cite

POPS4, Edgar & Edgarette: Azitra, Inc. (AZTR) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/AZTR. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.